Psittacosis in Europe: An Unusual Increase in Cases of Chlamydophila psittaci 

In February 2024, five countries in the WHO European region (Austria, Denmark, Germany, Sweden and The Netherlands) reported an unusual increase in psittacosis cases in 2023 and at the beginning of 2024, particularly marked since November-December 2023. Five deaths were also reported. Exposure to wild and/or domestic birds was reported in most of the cases.  

Psittacosis is a respiratory infection caused by Chlamydophila psittaci (C. psittaci), the bacteria that often infects birds. Human infections occur mainly through contact with secretions from infected birds and are mostly associated with those who work with pet birds, poultry workers, veterinarians, pet bird owners, and gardeners in areas where C. psittaci is epizootic in the native bird population. Disease transmission to humans occurs mainly through inhalation of airborne particles from respiratory secretions, dried faeces, or feather dust. Direct contact with birds is not required for infection to occur. 

In general, psittacosis is a mild illness, with symptoms including fever and chills, headache, muscle aches and dry cough. Signs and symptoms usually develop within 5 to 14 days after exposure to the bacteria.  

Prompt antibiotic treatment is effective and allows avoiding complications such as pneumonia. With appropriate antibiotic treatment, psittacosis rarely (less than 1 in 100 cases) results in death. 

Human psittacosis is a notifiable disease in the affected countries in Europe. Epidemiological investigations were implemented to identify potential exposure and clusters of cases. National surveillance systems are closely monitoring the situation, including laboratory analysis of samples from wild birds submitted for avian influenza testing to verify the prevalence of C. psittaci among wild birds. 

Overall, five countries in the WHO European region reported an unusual and unexpected increase in reports of cases of C. psittaci.  Some of the reported cases developed pneumonia and resulted in hospitalization, and fatal cases were also reported. 

Sweden has reported a general increase in psittacosis cases since 2017, which could be associated with the increased use of more sensitive polymerase chain reaction (PCR) panels. The increase in reported psittacosis cases across all countries requires additional investigation to determine whether it is a true increase in cases or an increase due to more sensitive surveillance or diagnostic techniques. 

Currently, there is no indication of this disease being spread by humans nationally or internationally. Generally, people do not spread the bacteria that causes psittacosis to other people, so there is a low likelihood of further human-to-human transmission of the disease.  

If correctly diagnosed, this pathogen is treatable by antibiotics. 

WHO recommends the following measures for the prevention and control of psittacosis: 

  • increasing the awareness of clinicians to test suspected cases of C. psittaci for diagnosis using RT-PCR. 
  • increasing awareness among caged or domestic bird owners, especially psittacines, that the pathogen can be carried without apparent illness. 
  • quarantining newly acquired birds. If any bird is sick, contact the veterinarian for an examination and treatment. 
  • conducting surveillance of C. psittaci in wild birds, potentially including existing specimens collected for other reasons. 
  • encouraging people with pet birds to keep cages clean, position cages so that droppings cannot spread among them and avoid over-crowded cages. 
  • promoting good hygiene, including frequent hand washing, when handling birds, their faeces, and their environments. 
  • standard infection-control practices and droplet transmission precautions should be implemented for hospitalized patients. 

*** 

Reference:  

World Health Organization (5 March 2024). Disease Outbreak News; Psittacosis – European region. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON509 

*** 

Latest

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Dark Matter in the Centre of our Home Galaxy 

Fermi telescope made clean observation of excess γ-ray emission...

Newsletter

Don't miss

Notre-Dame de Paris: An Update on ‘Fear of Lead Intoxication’ and Restoration

Notre-Dame de Paris, the iconic cathedral suffered serious damages...

New Nanofiber Dressing for Efficient Wound Healing

Recent studies have developed new wound dressings which accelerate...

Longevity: Physical Activity in Middle and Older Age is Crucial

Study shows that engaging in long-term physical activity can...

Climate Change: Greenhouse Gas Emissions and Air Quality are not Two Separate Problems

Climate change as a result of global warming attributed to...

What are we ultimately made up of? What are the Fundamental Building Blocks of the Universe?

Ancient people thought we are made up of four...

Moderate Alcohol Consumption May Decrease Risk of Dementia

A study suggests that both excessive consumption of alcohol...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which fundamental particles make dark matter, why matter dominates the universe and why there is matter-antimatter asymmetry, what is force...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

I agree to these terms.